G. Paolo M. Rizzardi, MD

Co-Founder &
Managing Partner

– 15+ years in biotechnology industry (2+ years as General Manager)

– Pivotal in the 1st Italian spinoff (MolMed SpA) from bench to IPO, and to market approval of first ATMPs in ex vivo cell&gene therapy for rare diseases and oncology

– Managed drug discovery, R&D, CMC, clinical development, engineering and IP from target validation to market approval

– Managed interactions with regulators (EMA, FDA, AIFA)

– Managed project, set-up and authorisation for market of large GMP facilities for cell&gene therapy products

– Managed significant expansion of business in cell&gene therapy services along with high-value negotiations with academia and pharma and biotech industry

– Managed scouting & evaluation of projects for in-licensing

10+ years clinical and R&D experience in academia in Switzerland, UK and Italy, in Internal Medicine and Infectious Diseases divisions

– Clinical activity in major university hospitals in Switzerland and Italy

– Clinical trials design and coordination for HAART and innovative immune-based/vaccination strategies in patients with HIV/AIDS

– 80+ peer-reviewed publications

– 4000+ citations

h-index 31